Ceftriaxone (Ceftriaxon)

2011  relevant articles (366 outcomes, 316 trials/studies) found for this Drug

Ceftriaxon; Ceftriaxone Sodium; Rocephin; Benaxona; Boehringer Mannheim Brand of Ceftriaxone Sodium; Cefatriaxone; Cefaxona; Ceftrex; Ceftriaxon Curamed; Ceftriaxon Hexal; Ceftriaxona Andreu; Ceftriaxona LDP Torlan; Ceftriaxone Irex; Ceftriaxone Sodium, Anhydrous; Ceftriaxone, Disodium Salt; Ceftriaxone, Disodium Salt, Hemiheptahydrate; Columbia Brand of Ceftriaxone; Curamed Brand of Ceftriaxone Sodium; Fustery Brand of Ceftriaxone Sodium; Galen Brand of Ceftriaxone Sodium; Hexal Brand of Ceftriaxone Sodium; Hoffman-La Roche Brand of Ceftriaxone Sodium; Inibsa Brand of Ceftriaxone Sodium; Irex Brand of Ceftriaxone; Lendacin; Longacef; Longaceph; Pisa Brand of Ceftriaxone Sodium; Ro 13-9904; Ro-13-9904; Ro13-9904; Rocefalin; Rocefin; Rocephine; Roche Brand of Ceftriaxone Sodium; Syntex Brand of Ceftriaxone Sodium; Tacex; Terbac; Anhydrous Ceftriaxone Sodium; Hoffman La Roche Brand of Ceftriaxone Sodium; Ro 13 9904; Ro 139904; Ro13 9904; Ro139904; Sodium, Ceftriaxone; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio)methyl)-, (6R-(6alpha,7beta(Z)))-

Relationship Network

Drug Context: Research Results

Experts

1.	Woods, Gail L: 6 articles (06/2004 - 04/2002)
2.	Cottagnoud, M: 3 articles (06/2007 - 08/2000)
3.	Cottagnoud, P: 3 articles (06/2007 - 08/2000)
4.	Pahissa, Albert: 3 articles (04/2007 - 02/2002)
5.	Gerber, Joachim: 3 articles (12/2004 - 07/2002)
6.	Nau, Roland: 3 articles (12/2004 - 07/2002)
7.	Carides, Alexandra: 3 articles (06/2004 - 04/2002)
8.	Jiang, Qi: 3 articles (06/2004 - 07/2002)
9.	Gesser, Richard M: 3 articles (06/2004 - 07/2002)
10.	Cornely, O A: 3 articles (06/2003 - 01/2000)

Related Diseases

1.	Infection 06/01/1988 - "As in earlier studies, which primarily used a twice-daily dosage regimen, few significant differences were found between therapeutic groups in comparative studies and results have demonstrated the efficacy of once-daily ceftriaxone in all but the most serious infections, such as sole antibiotic therapy in pseudomonal infections. " 04/15/1988 - "Our clinical studies demonstrated that an infection prophylaxis in gynaecological obstetrical standard operations is very effective with a single application of 1 g Ceftriaxone. " 08/01/1997 - "Treatment with ceftriaxone resulted in a marked improvement of neuropathic symptoms, providing indirect evidence of spirochetal infection. " 06/01/1984 - "If more widespread use confirms the safety and efficacy of ceftriaxone, it will offer an important alternative, particularly for the treatment of serious infections due to multidrug-resistant Gram-negative bacteria and in situations where the long half-life of the drug could result in worthwhile convenience and cost benefits." 06/01/2006 - "The aim of this study was to investigate (a) whether PCT could serve as a negative predictive marker for postoperative complications and (b) whether, in patients with elevated PCT levels, a pre-emptive treatment with the third-generation cephalosporin ceftriaxone is superior to an antibiotic treatment starting later on the appearance of clinical signs and symptoms of infection. " Order ALL the reference details at left...
2.	Pneumonia (Pneumonitis) 09/01/1991 - "One gram once daily of ceftriaxone is as effective as 2 gm for the common causative organisms of community-acquired and nosocomial pneumonias. " 07/01/1994 - "The effect of cytostatic treatment on the cellular defence and the efficacy of treatment with ceftriaxone in Klebsiella pneumoniae pneumonia was studied. " 07/01/2008 - "Ceftriaxone injection was used in 87% and 77% of the encounters in ARI/pneumonia in Companygonj and Sonaimuri UHCs respectively. " 08/01/2005 - "OBJECTIVE: To assess the effectiveness and safety of implementing an inpatient management and discharge strategy based on empiric antibiotic therapy with ceftriaxone sodium and a guideline to promote timely discharge for clinically stable patients hospitalized with community-acquired pneumonia. " 03/01/2000 - "PATIENTS AND METHODS: Forty patients admitted due to community acquired pneumonia, initially treated with ceftriaxone 1 g/day i.v. and that showed clinical improvement after three days of therapy, were studied. " Order ALL the reference details at left...
3.	Meningitis 08/09/1985 - "Several controlled comparative studies indicate that ceftriaxone is as effective as conventional treatment in therapy for neonatal or childhood meningitis caused by Streptococcus agalactiae, Escherichia coli, or H. " 05/01/1995 - "A combination of ceftriaxone and ABPC, both of which were sensitive to the pathogen, were intravenously administered for one month, by which he responded well as to the meningitis. " 02/01/1984 - "Ceftriaxone, as a single agent, was comparable in efficacy with traditional antimicrobial therapy usually employed in childhood meningitis." 01/01/1983 - "The efficacy of ceftriaxone against group B streptococci was studied in vitro and in vivo with an infant rat model of group B streptococci bacteraemia and meningitis. " 09/01/1991 - "Short-course, once-daily therapy with ceftriaxone requires more study; currently, many pediatricians administer the agent twice daily for suspected or proven meningitis. " Order ALL the reference details at left...
4.	Endocarditis 01/08/1992 - "CONCLUSIONS.--Ceftriaxone sodium administered at a once-daily dose of 2 g appears to be an effective and safe treatment of streptococcal endocarditis. " 03/01/1993 - "To date, there are two published studies on the treatment of nonenterococcal streptococcal endocarditis by ceftriaxone in humans. " 05/01/2001 - "A case of infective endocarditis caused by a viridans group streptococcus resistant to ceftriaxone." 01/01/1998 - "Efficacy and safety of ceftriaxone (Oframax, Ranbaxy, India) in the treatment of 25 patients with Staphylococcus endocarditis (SE) were studied. " 01/01/1998 - "[Ceftriaxone in the treatment of staphylococcal endocarditis]" Order ALL the reference details at left...
5.	Gonorrhea 08/01/1995 - "Our data suggest that most prepubertal children with gonorrhea are symptomatic at initial presentation and are cured after recommended treatment with ceftriaxone. " 07/01/1989 - "The Centers for Disease Control now recommends ceftriaxone for the first line treatment of gonorrhea but there are no data as to its use in children for this indication. " 10/01/1987 - "We retrospectively analyzed the efficacy of ceftriaxone in a single dose of 125 mg given intramuscularly for treatment of uncomplicated gonorrhea. " 10/01/1987 - "These results confirm those of earlier clinical trials showing that 125 mg of ceftriaxone is effective therapy for uncomplicated gonorrhea in a geographic area with a high prevalence of gonococci with chromosomally mediated antibiotic resistance." 12/01/1981 - "Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Cefotaxime (Kendrick)
2.	Penicillins (Penicillin)
3.	Ampicillin (Omnipen)
4.	Gentamicins (Gentamicin)
5.	Vancomycin
6.	Ciprofloxacin (Cipro)
7.	Chloramphenicol (Chloromycetin)
8.	Cephalosporins (Cephalosporin Antibiotics)
9.	Cefuroxime (Zinacef)
10.	Anti-Bacterial Agents (Antibiotics)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Intramuscular Injections
3.	Antibiotic Prophylaxis
4.	Injections
5.	Oral Administration